Incyte INCY has put up a good performance in the past three months. Shares of the company have gained 9.2% against the industry’s decline of 1.3%. The stock has also outperformed the sector in the ...

Bristol-Myers Squibb faces revenue declines but offers long-term potential via growth drugs. Read what BMY stock has to offer ...

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries at risk of ineffective treatments and potentially fatal side effects, an ...

The worst-performing drug in the study is made by Indian manufacturer Venus Remedies. It is called cyclophosphamide, a drug ...

Scientists discover how cells absorb queuosine, a vital nutrient affecting memory, learning, and cancer resistance.

In the first half of 2025, researchers around the world have published a wave of peer-reviewed studies examining the effects ...

Doctors warn patients in the public health system could end up waiting longer if those with insurance are prioritised.

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

Once a suspect COVID cure, now a right-wing aspirin. As a physician who diagnoses cancer, I have come across this line of ...

The list, which includes 15 drugs, ... Pomalyst, a chemotherapy drug. Ibrance, a breast cancer drug. Ofev, for idiopathic pulmonary fibrosis. Linzess, a chronic constipation drug.